Irackly Mtibelishvily
Nessuna posizione attualmente
Profilo
Irackly Mtibelishvily worked as a Director at Argos Therapeutics, Inc. from 2016 to 2018.
He graduated from Moscow State Institute of International Relations and the University of Virginia School of Law with graduate degrees.
Precedenti posizioni note di Irackly Mtibelishvily
| Società | Posizione | Fine |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 30/11/2018 |
Formazione di Irackly Mtibelishvily
| University of Virginia School of Law | Graduate Degree |
| Moscow State Institute of International Relations | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Irackly Mtibelishvily
